During the past decade, Institute of Oncology at Prince of Wales Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of Oncology at Prince of Wales Hospital" #1 sponsor was "ETOP IBCSG Partners Foundation" with 2 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Cellxpert Biotechnology Corp." with 1 trials sponsored, "NHS Greater Glasgow and Clyde" with 1 trials sponsored and "Royal Liverpool University Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Oncology at Prince of Wales Hospital" #1 collaborator was "Australasian Gastro-Intestinal Trials Group" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "Arbeitsgruppe Lebermetastasen und Tumoren" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator and "Cancer Research UK" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Oncology at Prince of Wales Hospital" are "Breast Cancer" (2 trials), "Cognitive/Functional Effects" (1 trials), "Colorectal Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Fatigue" (1 trials). Many other conditions were trialed in "Institute of Oncology at Prince of Wales Hospital" in a lesser frequency.

Most popular intervention types in "Institute of Oncology at Prince of Wales Hospital" are "Drug" (5 trials), "Procedure" (3 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (2 trials), "leucovorin calcium" (2 trials), "CHOP regimen" (1 trials), "Dual energy X-ray absorptiometry (DEXA)" (1 trials) and "FOLFOX regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Oncology at Prince of Wales Hospital" are 4 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Institute of Oncology at Prince of Wales Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Institute of Oncology at Prince of Wales Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Oncology at Prince of Wales Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".